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Abstract
Does carotid intima–media thickness (cIMT), a surrogate marker of cardiovascular events, have predictive incremental value over
established risk factors for stable coronary artery disease (CAD)? Prospective study of 300 patients, with suspected stable CAD,
admitted for an elective coronary angiography and carotid ultrasound. The CAD patients had a higher cIMT, which showed a
modest predictive accuracy for CAD (area under the receiver–operating characteristic curve 0.638, 95% confidence interval
0.576-0.701, P < .001). The cIMT was an independent predictor of CAD, together with age, gender, and diabetes. C-statistic for
CAD prediction by traditional risk factors was not significantly different from a model that included cIMT, carotid plaque pres-
ence, or both. However, in women, it was significantly increased by the addition of cIMT or carotid plaque presence. Although
cIMT cannot be used as a sole indicator of CAD, it should be considered in the panel of investigations that is requested, partic-
ularly in women who are candidates for coronary angiography.
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Introduction
Cardiovascular diseases are the leading cause of death in devel-
oped countries.1 They are also a major problem in Portugal, not
only as far as coronary artery disease (CAD) is concerned but
also in terms of stroke, the incidence of which is among the
highest in the world.2 In fact, in developed countries, the most
common cardiovascular disease is CAD, which is also the lead-
ing cause of death in all the European Union with the exception
of Greece, the former Yugoslav Republic of Macedonia and
Portugal, where it is stroke.2 It is thus important to identify
patients at risk of developing cardiovascular events to enable
preventive interventions and promote lifestyle modifications.
Traditional risk prediction scores have proven very useful in
identifying persons at risk of coronary heart disease, but such
tools have limitations. Carotid intima–media thickness (cIMT)
is a well-described surrogate marker for cardiovascular disease
that it is easily obtained by a noninvasive test and increased
cIMT has been associated with prevalent and incident CAD and
stroke.3-6 Furthermore, plaque presence, which has been shown
to be associated with coronary heart disease independent of
cIMT measurement in several studies, seems to improve risk
prediction.7,8 However, most studies addressed the relationship
between cIMT and acute cardiovascular events in the follow-
up.5,6 Fewer studies analyzed the relationship between cIMT
and angiographic coronary artery disease—a stable end point
with different pathopysiological mechanisms.
In the present study, we aimed to investigate the relationship
between cIMT and angiographic CAD in patients evaluated by
coronary angiography for suspected CAD. We intended to pro-
vide more information to help answer two important questions.
Is cIMT evaluation useful in clinical practice? Does it help to
define indications for coronary angiography?
Population and Methods
The present study is an observational and cross-sectional study,
with prospective inclusion of patients admitted for an elective
coronary angiography with suspected CAD (with stable
angina and/or with documented ischemia on noninvasive
tests). All patients had an age 18 years. Patients with previ-
ous acute coronary syndromes, myocardial revascularization
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procedure, valvular heart disease, congenital heart disease, or
cardiomyopathy were excluded. The local institutional ethics
committee approved the study, and all patients gave their
written informed consent.
Blood pressure (BP) was measured on several occasions
during hospital stay and hypertension was defined by a previ-
ous diagnosis of hypertension or the presence of systolic BP
 140 mm Hg or diastolic BP  90 mm Hg (mean of 2 consec-
utive measurements). Patients that smoked during the previous
6 months were classified as smokers and were self-reported.
Diabetes was recorded by patient history, raised glucose (fasting
level 126 mg/dL), or use of specific therapies.
A venous blood sample was drawn after a 12-hour over-
night fast. All the samples were analyzed at the central
laboratory of the hospital. Serum glucose, total cholesterol,
and triglycerides were determined using automatic standard
routine enzymatic methods. High-density lipoprotein (HDL)
cholesterol was determined after specific precipitation. Low-
density lipoprotein (LDL) cholesterol was determined by
Friedewald formula.
Coronary angiography was performed by the standard
Judkins technique. The coronary angiograms were analyzed
using QCA software, Cardiovascular Measurements System
(QCA-CMS) version 6.0 (Medis Medical Imaging Systems,
Leiden, The Netherlands) by a single operator blinded to the
carotid ultrasound results. An automated edge detection algo-
rithm determined vessel centerline and contour and absolute
reference vessel and minimum lumen diameters were deter-
mined using the calibration factor. Percentage stenosis was cal-
culated from minimum lumen diameter and a normal reference
value obtained as an extrapolation of the proximal and distal
segments surrounding the stenosis. Significant angiographic
CAD was defined as stenosis of 50% or more in any coronary
vessel. The severity of CAD was assessed by the Gensini score,
a previously validated method.9 The interclass correlation coef-
ficients for intrareader reproducibility were 0.950 for Gensini
score and 0.724 to 0.947 for vessel dimension (analyzed for dif-
ferent vessels), which suggests good agreement.
The carotid ultrasound procedure was performed with a
Siemens Sonolite system and a 7.5-MHz linear array transdu-
cer. The cIMT was measured by a trained radiologist (blinded
to the coronary angiographic result) at the distal common car-
otid artery (CCA; 1 cm proximal to dilation of the carotid bulb)
at the far wall. The higher yield and superior reproducibility of
measurement of the CCA IMT compared to internal carotid
artery (ICA) and bulb IMT favor its use in the IMT measure-
ments, and this was the segment chosen for the study. Manual
measurements were taken and the value of both the right and
the left side were obtained for analysis. The final cIMT was
obtained as the maximum cIMT between both sides. Plaque
was defined as a focal structure encroaching into the arterial
lumen with a thickness that is more than 50% of the surround-
ing cIMT or more than 1.5 mm. The interclass correlation
coefficients for intrareader and interreader reproducibility
were 0.907 and 0.820, respectively, which also suggests good
agreement.
Statistical Analysis
Statistical analysis was conducted using the PASW 18.0
program (SPSS Inc, Illinois, Chicago). Quantitative variables
were described as mean and standard deviation or as median
values and corresponding 25th and 75th percentiles for nonnor-
mally distributed variables and qualitative variables as percen-
tages. Student t test or Mann-Whitney U test was used for
between-group comparisons of continuous variables (accord-
ing to distribution characteristics), while the chi-square test
was used for between-group comparisons of categorical vari-
ables. Gensini score and some laboratory variables were much
skewed, and we performed a 10-based logarithmic transforma-
tion (Log) that was used in the subsequent analysis. Pearson
correlation was done between cIMT and continuous variables.
Bivariate logistic regression models were used to identify pre-
dictors of CAD. Multivariate logistic regression analysis (with
CAD as the outcome variable) was performed to determine
whether cIMT was an independent predictor of CAD. We used
the area under the receiver–operating characteristic (AUC)
curve analysis (or C-statistics) to evaluate predictive value for
CAD of cIMT and to determine its best cutoff (maximizing the
sum of sensitivity and specificity). Several risk prediction mod-
els were also considered: (1) established risk factors only, (2)
established risk factors plus cIMT, (3) established risk factors
plus carotid plaque, and (4) established risk factors plus cIMT
plus carotid plaque. We described the AUC for each model to
analyze the model predictive capacity.
Results
We included 300 patients in the study, with a mean age of 64+
9 years (aged 38-86 years), 59% males (Table 1). Significant
CAD was present in 51.3% of patients, but it was significantly
lower in females (35.8% vs 62.1%; P < .001). Patients with sig-
nificant CAD were older, more frequently male and diabetic,
had higher levels of blood glucose and triglycerides, and lower
levels of HDL cholesterol (Table 1).
In our population, 88% of the patients had a noninvasive test
positive for ischemia. However, even in this group of patients,
the prevalence of significant CAD was low, particularly in
females (Table 2).
Mean cIMT was 0.88 + 0.33 mm, significantly higher in
males (0.94 + 0.35 vs 0.81 + 0.29 mm; P ¼ .001) and in
patients with significant CAD (0.96 + 0.35 vs 0.82 + 0.29
mm; P < .001). Carotid plaques were present in 6.0% of patients.
The cIMT was associated with the number of diseased coron-
ary vessels; however, the only significant difference was found
between no diseased vessel and 1 diseased vessel (Figure 1).
A more consistent association was found between cIMT and
Gensini score, a CAD severity index (r ¼ .221, P < .001).
By receiver–operating curve analysis, we obtained a modest
predictive capacity for CAD of isolated cIMT (AUC 0.638,
95% confidence interval [CI] 0.576-0.701; P < .001), with the
best cutoff of 0.85 mm with a sensitivity of 63% and specificity
of 64%. The same cutoff was obtained in both genders, however
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with a better AUC for women (Table 3). In a logistic regression
model for CAD, cIMT was an independent predictor of CAD, as
well as age, gender, and diabetes (Table 4). Even when cIMT
was introduced in the model as a categorical value using the
previous obtained cutoff, it remained as an independent predictor
of CAD (odds ratio 2.26, 95% CI 1.36-3.75; P ¼ .002).
To analyze the incremental value of cIMT and carotid pla-
ques over established risk factors, we compared risk prediction
models. We found that the AUC for traditional risk factor pre-
diction of CAD was not significantly different from the model
that included cIMT, carotid plaque presence, or both (Table 5).
However, in women, it was substantially increased by the addi-
tion of cIMT or carotid plaque presence, and the combination
of risk factors, cIMT, and plaque yielded the highest AUC.
Discussion
Our study showed a surprisingly low diagnostic yield of coron-
ary angiography. However, recent registries point to the same
results. In a 1992 report, between 9% and 36% of patients who
underwent invasive angiography were found to have normal
coronary arteries, but the findings were limited by varying def-
initions of normal and by different radiographic equipment.10
Findings from the Coronary Artery Surgery Study showed that
18.8% of patients had nonobstructive CAD.11 Data from the
Society for Cardiac Angiography and Interventions (still more
than 15 years old) showed that between 30% and 35% of
patients had stenosis of less than 50%.12 These data were
obtained before the current increase in both noninvasive
imaging and the use of cardiac catheterization and include a
broad spectrum of patients undergoing angiography, including
those with acute coronary syndromes and other emergency indi-
cations. Thus, the definition of the patient population is critical
in placing our findings in context. The recently published Cath-
PCI Registry of the National Cardiovascular Data Registry
(NCDR), a large registry of clinical data and in-hospital outcome
data associated with diagnostic cardiac catheterization and
percutaneous coronary interventions collected from more than
800 US sites reported also a low diagnostic yield in patients
Table 1. Characteristics of the Study Population and by Gender
Characteristics Total CAD No CAD
P
Mean + SD Mean + SD Mean+ SD
Median (IQR)
%
Median (IQR)
%
Median (IQR)
%
Age (years) 64.4+ 9.2 66.2+ 9.2 63.4 + 9.9 .003
Male gender (%) 59 71 46 .001
Risk factors (%)
Hypertension 79 87 84 .604
Hyperlipidemia 70 70 69 .957
Smoking 9 11 8 .398
Diabetes mellitus 23 29 16 .013
Laboratorial data
Glucose (mg/dL) 100 (92-115) 104 (93-124) 97 (91-106) .001
Total cholesterol (mg/dL) 181 (155-213) 182 (158-218) 177 (152-207) .208
HDL-cholesterol (mg/dL) 43 (36-54) 41 (34-50) 47 (40-55) <.001
LDL-cholesterol (mg/dL) 114 (93-136) 114 (97-141) 114 (89-133) .141
Triglycerides (mg/dL) 97 (68-134) 100 (71-146) 93 (63-124) .019
Abbreviations: SD, standard deviation; IQR, interquartile range; CAD, coronary artery disease; HDL, high-density lipoprotein; LDL, low-density lipoprotein.
Table 2. Prevalence of Significant Coronary Artery Disease, Analyz-
ing Only Patients With Positive Stress Tests and According to Gender
Total, % Males, % Females, % P
Positive treadmill test 49.3 60.7 30.8 .001
Positive nuclear test 54.3 65.2 41.4 .012
Any positive test 51.5 62.7 36.0 <.001
Figure 1.Carotid intima–media thickness according to the number of
diseased coronary arteries (P ¼ .003, post hoc analysis with the only
significant difference between no-vessel and 1-vessel disease).
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without previously known CAD, with only a minority of
patients with obstructive CAD (41.0%) similar to our
results.13 This registry represents contemporary clinical
practice in the community. The NCDR registry also pro-
vides insights into patterns of noninvasive testing among
patients undergoing diagnostic cardiac catheterization. Pre-
vious studies showed that only 41% of the patients under-
went any stress testing before coronary angiography.14
The NCDR registry showed that up to 84% of patients
undergoing angiography had undergone a previous noninva-
sive diagnostic test and a positive result was recorded in
68.6% of all patients in the cohort.13 Similar results were
obtained in our population. The increased use of noninva-
sive testing to rule out ischemia prior to the procedure
should result in more effective risk stratification of patients,
allowing identification of those patients who would be most
likely to benefit from cardiac catheterization and ideally
reducing the use of invasive procedures in patients who
do not have obstructive disease. Although certain demo-
graphic and clinical characteristics could be useful in
determining the likelihood that obstructive CAD would be
present, the incremental value of a positive result on a non-
invasive test was however limited. In NCDR registry,
although the association between a positive noninvasive test
and the presence of obstructive CAD was significant, the
effect of a positive noninvasive test on the ability of the
model to predict the presence of obstructive CAD was lim-
ited with minimal increase in C-statistic.13 It is also impor-
tant to stress out that patients with chest pain and normal or
nonobstructive coronary angiograms are predominantly
women, and many have a prognosis that is not as benign
as previously thought.15 Assessment of endothelial function
may help identify patients at risk of future cardiac events.
Recent data suggest that ST-segment changes and myocar-
dial reversible perfusion defects in patients with ‘‘normal’’
coronary arteries may be true myocardial ischemia likely
related to atherosclerotic disease and not false-positive test
results.15
Our study confirmed the limited value of noninvasive tests,
particularly in women. Thus, there is still need of an inexpen-
sive and easily accessible test that would indicate the likelihood
of CAD with reasonable high sensitivity and specificity. A
meta-analysis of 8 trials on cIMT, including 37 197 asympto-
matic individuals who were followed up for a mean of 5.5 years
showed that a cIMT increment of 0.1 mm increased the risk of
myocardial infarction by 10% to 15% and increased the risk of
stroke by 13% to 18%, after adjusting for age and gender.16
Moreover, the cIMT prediction for both events may be better
in women than in men and the cIMT prediction may be better
for stroke than for CAD when cIMT is measured in the CCA
alone.6 The fact that cIMT provides additional prognostic
information to that of conventional risk factors is pivotal in dis-
cussing its clinical utility in primary prevention and was not
supported by available data until recently. Since 2000, 7 guide-
lines or consensus statements recommended measuring
cIMT and/or carotid plaque detection as clinical tools to assist
cardiovascular disease risk prediction.17 However, the US Pre-
ventive Services Task Force recently recommended against
measurement of anatomical markers of atherosclerosis, includ-
ing cIMT, basing its negative recommendation regarding the
independent predictive value of cIMT for patients at intermedi-
ate CAD risk and concerns about this test’s ability to reclassify
such patients into lower or higher risk categories, therefore
altering their clinical management.18,19 The very recent report
from the Atherosclerosis Risk in Communities (ARIC) study
with >13 000 individuals provide the best evidence, to date,
demonstrating the ability of carotid ultrasound data to improve
CAD risk prediction.20 They found that the AUC for estab-
lished risk factor prediction of CAD events was significantly
increased by the addition of increased cIMT or carotid plaque
presence and that the combination of risk factors, cIMT, and
plaque yielded the highest AUC. Thus, carotid ultrasound-
based cIMTmeasurement and identification of plaque presence
or absence improves CAD risk prediction and should be con-
sidered in the intermediate risk group.
These findings support the previous American Society of
Echocardiography’s recommendation of combining cIMT and
carotid plaque data for optimal risk prediction.17 In the ARIC
report, although the increments in AUC achieved using the car-
otid ultrasound data may seem small, they are on the same
order of magnitude as the individual contributions of smoking
status and systolic BP and greater than the contributions of
lipids, family history, and high-sensitivity C-reactive protein.20
Table 3. Evaluation of cIMT Gender-Specific Cutoff Values for the Presence of Significant Coronary Artery Disease by ROC Curve Analysis
Cutoff Se Sp AUC P RR for CAD (95% CI)
Females 0.85 mm 64% 75% 0.715 (0.621-0.809) <.001 5.16 (2.33-11.45)
Males 0.85 mm 63% 52% 0.557 (0.470-0.645) .201 1.84 (0.99-3.41)
Abbreviations: ROC, receiver-operating curve; Se, sensitivity; Sp, specificity; AUC, area under curve; RR, relative risk; CAD, coronary artery disease; CI, confi-
dence interval.
Table 4. Backward Multivariate Logistic Regression Model to Predict
Coronary Artery Disease
B Wald OR (95% CI) P
Age 0.033 5.442 1.03 (1.01-1.06) .020
Male gender 1.068 17.300 2.91 (1.76-4.81) <.001
Diabetes 0.693 5.156 2.00 (1.10-3.64) .023
cIMT 0.855 4.199 2.35 (1.04-5.33) .040
Abbreviations: OR, odds ratio; CI, confidence interval; cMIT, carotid intima–
media thickness.
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Indeed, after age and gender inclusion in predictive models,
additional risk factors contribute little on an individual basis
but are very important when considered together.20
In the past few years, several groups have shown that carotid
plaque or plaque area are more closely related to CAD and is
more strongly predictive of coronary events.5,8,21-24 In fact,
established coronary risk factors explain only 15% to 17% of
cIMT but account for 52% of the carotid plaque area, suggest-
ing that the carotid plaque area is more representative of ather-
osclerotic burden than cIMT.25-27 Although highly
intercorrelated, measurements of cIMT and plaque area proba-
bly reflect different biological aspects and stages in the devel-
opment of atherosclerosis. Whereas plaque is the biological
hallmark of atherosclerosis, reflecting subendothelial deposi-
tion of cholesterol as well as infiltration of inflammatory cells,
a diffuse thickening of the intima–media layer may be caused
by other pathogenic mechanisms. In this layer, 20% is made
of the endothelial layer and subendothelial matrix, and the
remaining 80% consists of smooth muscle cells.27 Age-
related arterial stiffness and hypertension increase the shear
forces acting on the vessel surface, causing hyperplasia of the
smooth muscle cells, explaining the association of cIMT with
age and hypertension.27 Increased cIMT therefore may not
necessarily reflect the atherosclerotic process. On the other
hand, plaque growth occurs longitudinally along the carotid
axis of flow faster than it thickens, which may make plaque
area more sensitive as a measure of atherosclerosis.28
The present study analyzed directly the relationship between
carotid subclinical atherosclerosis and stable significant angio-
graphic coronary artery disease. This end point is different
from the most often studied end points since acute cardiovascu-
lar events are caused by unstable atherosclerotic plaques, with
different pathophysiological mechanisms involved when com-
pared to stable atherosclerotic plaques. Our results showed that
cIMT is higher in patients with significant CAD than in patients
without CAD. Regression analysis revealed that thickening of
the mean intima–media complexmore than 0.85mmwas predic-
tive of significant CAD. As an isolated tool, its predictive capac-
ity for CAD is, however, very modest but slightly better in
women. We also found that although in the general population,
it was not very helpful in increasing predictive capacity for CAD
when added to a predictive model with conventional risk factors,
in women there was a substantial incremental value of cIMT
to predict significant CAD and that it was slightly better than
carotid plaque. Therefore, cIMT value cannot be used as a sole
indicator of CAD but needs to be considered in the panel of stud-
ies that is requested, particularly in women who are considered
candidates for coronary angiography.
Both cIMT and carotid plaques seemed to have a more
profound effect on improving risk prediction in women than
in men, and the reason is not completely clear. The most likely
explanation is that middle-aged women have a relatively low
prevalence of atherosclerosis. For that reason, increased cIMT
and plaque presence, which reflects a definite area of athero-
sclerosis, is more powerful in predicting CAD.
In conclusion, coronary angiography has a low diagnostic
yield for significant CAD, particularly in women. In this group,
noninvasive tests for risk stratification before coronary angio-
graphy also have severe limitations. In women, cIMT seems
to be a useful risk stratification tool in association with conven-
tional risk factors for CAD.
Limitations
Our study is a cross-sectional study, and as such, it is not pos-
sible to establish a causal relationship since no information
from the follow-up was analyzed and individuals only under-
went a single coronary angiogram and carotid ultrasound.
The present scanning protocol for cIMT measurement only
focuses on the CCA due to difficulties in adequate evaluation
of cIMT in the bulb and ICA. However, scanning of the remain-
ing segments of the carotid arteries for plaques might be impor-
tant to avoid missing ‘‘upstream’’ advanced atherosclerosis. In
fact, we did not account for the potential difference between
plaque presence in one artery alone versus in multiple arteries.
It is possible that plaque presence in multiple carotid artery seg-
ments may be associated with higher risk. Very recent studies
showed that cIMT measured solely in the far wall of the CCA
is associated with incident stroke in unadjusted analysis, but
this association became nonsignificant after adjustment for
Table 5. Predictive Value for Each Modela
Model 1 Model 2 Model 3 Model 4
Overall
AUC (95% CI) 0.701 (0.642-0.760) 0.709 (0.651-0.768) 0.707 (0.649-0.766) 0.709 (0.651-0.768)
P .613 .001 .521 <.001
Males
AUC (95% CI) 0.636 (0.551-0.720) 0.630 (0.547-0.719) 0.638 (0.554-0.723) 0.641 (0.557-0.725)
P .920 .519 .532 .727
Females
AUC (95% CI) 0.689 (0.591-0.788) 0.745 (0.656-0.834) 0.717 (0.621-0.812) 0.747 (0.658-0.836)
P .552 .887 .383 .969
Abbreviations: cIMT, carotid intima–media thickness; CI, confidence interval; AUC, area under the curve.
a Risk prediction models: (1) established risk factors only; (2) established risk factors plus cIMT; (3) established risk factors plus carotid plaque; (4) established risk
factors plus cIMT plus carotid plaque. P values derived using the Hosmer and Lemeshow test.
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risk factors.29,30 However, using measurements that included
the carotid bifurcation, where there is a nonlaminar turbulent
flow that favors atherosclerotic plaque development, it was
associated with stroke but only in women.30 This highlights
the importance of segment-specific measurements as well as
gender influence.
Manual assessment of cIMT is not optimally reproducible.
There have been rapid advances in ultrasound technology
resulting in greater consistency and resolution of images.
Semiautomated edge-detection software to measure cIMT has
been developed and has been found to be both accurate and repro-
ducible. This technology might have yielded different results.
This is an angiographic study and as such, coronary
plaque morphology was not directly assessed. Intravascular
ultrasound allows cross-sectional imaging of coronary arteries
and provides more comprehensive assessment of atherosclero-
tic plaque in vivo and this is considered the gold standard tech-
nique. With quantitative coronary angiography analysis, we
measured reference diameter and percentage diameter stenosis.
However, it has been previously described that this measure-
ment might be misleading because patients with identical mea-
surements in angiography might have different vessel volume
and plaque volume when assessed by intravascular ultrasound.
In fact, in some patients, vessels might have a compensatory
enlargement to prevent building atheroma from encroaching
in lumen, thereby concealing the presence of a lesion when
angiography is performed.31
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